Drawing for WINDTREE THERAPEUTICS

USPTO serial 87003044

WINDTREE THERAPEUTICS

Reviewed by CopyMark Law Group

Reg. 5967726Status 710
Filing date
Status date
Registration date
Jan 21, 2020
Examiner
CLARKE, NANCY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with WINDTREE THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Janet E. Reed

Janet E. Reed Potter Anderson & Corroon LLP1313 North Market StreetWilmington, DE 19801United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases and disorders; Pharmaceutical preparations, namely, synthetic pulmonary surfactants for treatment of respiratory conditionsSECTION 8 - CANCELLEDDec 13, 2019
010Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmaceutical preparations and substances; Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmaceutical preparations and substances for treatment of various medical conditions; Medical device, namely, an adapter for facilitating entrainment of liquid, powder or aerosolized pharmaceutical preparations and substances; aerosol dispensers for medical use not filled with pharmaceuticals; medical apparatus which uses heat to generate aerosolized pharmaceutical preparations and substances which is then delivered to patientsSECTION 8 - CANCELLEDSep 12, 2019
042Pharmaceutical research, drug discovery, and drug development services; medical and scientific research in the field of pulmonary diseases; research and development of pharmaceutical preparations for the treatment of pulmonary diseases and disorders; research and development of pharmaceutical preparations and substances for treatment of respiratory conditions; research and development of new products in the field of surfactant replacement therapies for respiratory diseases; research and development of pharmaceutical preparations, namely, pulmonary lung surfactants; pharmaceutical research and development in the field of inhaled pharmaceutical products for all human respiratory indications; research and development services in the field of medical apparatus, appliances and instruments for producing and/or delivering aerosolized pharmaceutical preparations; providing scientific information about pharmaceutical products and services; providing scientific information about pharmaceutical products and services via a website and other forms of mediaSECTION 8 - CANCELLEDApr 18, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 31, 2026C8..CANCELLED SEC. 8 (6-YR)—
Jan 21, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 21, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 21, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 21, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 21, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 21, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 21, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 21, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 17, 2019SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Dec 16, 2019CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 15, 2019SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Dec 13, 2019IUAFUSE AMENDMENT FILED—
Dec 13, 2019EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 28, 2019EX5GSOU EXTENSION 5 GRANTED—
May 21, 2019EXT5SOU EXTENSION 5 FILED—
May 21, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 7, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 6, 2018EX4GSOU EXTENSION 4 GRANTED—
Dec 3, 2018EXT4SOU EXTENSION 4 FILED—
Dec 3, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 21, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 20, 2018EX3GSOU EXTENSION 3 GRANTED—
Jun 18, 2018EXT3SOU EXTENSION 3 FILED—
Jun 18, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 21, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 20, 2017EX2GSOU EXTENSION 2 GRANTED—
Dec 20, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 18, 2017EXT2SOU EXTENSION 2 FILED—
Dec 18, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 28, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 26, 2017EX1GSOU EXTENSION 1 GRANTED—
Jun 26, 2017EXT1SOU EXTENSION 1 FILED—
Jun 26, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 27, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 1, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 23, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 20, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 20, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Sep 20, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 20, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 20, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 19, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Sep 19, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 19, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 19, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 26, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 25, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 3, 2016CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Aug 3, 2016ALIEASSIGNED TO LIE—
Aug 2, 2016GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Aug 2, 2016GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Aug 2, 2016CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jul 31, 2016DOCKASSIGNED TO EXAMINER—
May 18, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 21, 2016MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance